Literature DB >> 19348915

Anti-IgE therapy: clinical utility beyond asthma.

Thomas B Casale, Jeffrey Stokes.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19348915     DOI: 10.1016/j.jaci.2009.02.016

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  6 in total

Review 1.  IgE, mast cells, basophils, and eosinophils.

Authors:  Kelly D Stone; Calman Prussin; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

Review 2.  Biologic modulators in allergic and autoinflammatory diseases.

Authors:  Lori Broderick; Louanne M Tourangeau; Arthur Kavanaugh; Stephen I Wasserman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-08

3.  Immunomodulators for asthma.

Authors:  Vesselin V Dimov; Thomas B Casale
Journal:  Allergy Asthma Immunol Res       Date:  2010-05-17       Impact factor: 5.764

4.  Omalizumab for severe atopic keratoconjunctivitis.

Authors:  Camille Taillé; Serge Doan; Catherine Neukirch; Michel Aubier
Journal:  BMJ Case Rep       Date:  2010-10-28

5.  Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.

Authors:  Alexander Eggel; Günther Baravalle; Gabriel Hobi; Beomkyu Kim; Patrick Buschor; Patrik Forrer; Jeoung-Sook Shin; Monique Vogel; Beda M Stadler; Clemens A Dahinden; Theodore S Jardetzky
Journal:  J Allergy Clin Immunol       Date:  2014-03-15       Impact factor: 10.793

6.  Successful treatment of refractory status asthmaticus with omalizumab: a case report.

Authors:  Jan Benes; Roman Skulec; Dalibor Jilek; Ondrej Fibigr; Vladimir Cerny
Journal:  Allergy Asthma Clin Immunol       Date:  2021-12-09       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.